Volume 3, Issue 3 (September 2017)                   Curr Med Mycol 2017, 3(3): 1-4 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kamali A, Mehni S, Kamali M, Taheri Sarvtin M. Detection of ochratoxin A in human breast milk in Jiroft city, south of Iran. Curr Med Mycol. 2017; 3 (3) :1-4
URL: http://cmm.mazums.ac.ir/article-1-160-en.html
Abstract:   (989 Views)
Background and Purpose: Breastfeeding plays an important role in the growth and development of infants. However, breast milk may be contaminated with various mycotoxins. Ochratoxin A is one of the most important mycotoxins with nephrotoxic, carcinogenic, teratogenic, genotoxic, and immunotoxic properties. Thus, we carried out this study to determine the concentration of ochratoxin A in human breast milk in Jiroft, Kerman Province, south of Iran.
Materials and Methods: Eighty-four human breast milk samples were collected from mothers visiting the number one clinic in Jiroft city. Enzyme-linked immunosorbent assay (ELISA) was used to detect ochratoxin A in the samples.
Results: Ochratoxin A was found in all the tested samples at a concentration ranging from 0.11 to 7.34 ng/ml. The mean concentration of ochratoxin A in the samples was 1.99±1.34 ng/ml. Fourteen samples contained ochratoxin A at concentrations exceeding the quantitation limit (3 ng/ml).
Conclusion: The results of this study showed that infants are exposed to ochratoxin A in our region. In cases exceeding the quantitation limit, the infant's body cannot detoxify the toxin. Therefore, the infant can be affected by various illnesses such as nephropathy, immune system deficiency, and different types of cancer.
Full-Text [PDF 397 kb]   (317 Downloads)    
Type of Study: Original Articles | Subject: Medical Mycology
Received: 2017/09/28 | Accepted: 2018/01/16 | Published: 2018/02/17

1. Kumar D, Barad S, Sionov E, Keller NP, Prusky DB. Does the host contribute to modulation of mycotoxin production by fruit pathogens. Toxins (Basel). 2017; 9(9):E280. [DOI:10.3390/toxins9090280]
2. Alshannaq A, Yu JH. Occurrence, toxicity, and analysis of major mycotoxins in food. Int J Environ Res Public Health. 2017; 14(6):E632. [DOI:10.3390/ijerph14060632]
3. Sarvtin MT, Hedayati MT, Abastabar M, Shokohi T. Debaryomyces hansenii colonization and its protein profile in psoriasis. Iran J Dermatol. 2014; 17(4):134-7.
4. Andrade PD, Dantas RR, Moura-Alves TLDS, Caldas ED. Determination of multi-mycotoxins in cereals and of total fumonisins in maize products using isotope labeled internal standard and liquid chr omatography/tandem mass spectrometry with positive ionization. J Chromatogr A. 2017;1490:138-47. [DOI:10.1016/j.chroma.2017.02.027]
5. Chang H, Kim W, Park JH, Kim D, Kim CR, Chung S, et al.The occurrence of Zearalenone in South Korean feedstuffs between 2009 and 2016. Toxins (Basel). 2017; 9(7):E223. [DOI:10.3390/toxins9070223]
6. Tittlemier SA, Drul D, Roscoe M, McKendry T. Occurrence of ergot and ergot alkaloids in western Canadian wheat and other cereals. J Agric Food Chem. 2015; 63(29):6644-50. [DOI:10.1021/acs.jafc.5b02977]
7. Sohrabi N, Gharahkoli H. A seasonal study for determination of aflatoxin M1 level in dairy products in Iranshahr, Iran. Curr Med Mycol. 2016; 2(3):27-31. [DOI:10.18869/acadpub.cmm.2.3.27]
8. Abastabar M, Akbari A, Akhtari J, Hedayati MT, Shokohi T, Mehrad-Majd H, et al. In vitro antitumor activity of patulin on cervical and colorectal cancer cell lines. Curr Med Mycol. 2017; 3(1):25-9. [DOI:10.29252/cmm.3.1.25]
9. Nazemi L, Kordbacheh P, Daei Ghazvini R, Moazeni M,Akbari Dana M, Rezaie S. Effects of thiamine on growth, aflatoxin production, and aflr gene expression in A.parasiticus.Curr Med Mycol. 2015;1(1):26-34. [DOI:10.18869/acadpub.cmm.1.1.26]
10. Duarte SC, Pena A, Lino CM. Ochratoxin A in Portugal: a review to assess human exposure. Toxins (Basel). 2010; 2(6):1225-49. [DOI:10.3390/toxins2061225]
11. Dehghan P, Pakshir K, Rafiei H, Chadeganipour M,Akbari M. Prevalence of Ochratoxin A in human milk in the Khorrambid town, Fars province, South of Iran. Jun dishapur J Microbiol. 2014; 7(7):e11220. [DOI:10.5812/jjm.11220]
12. Chen C, WuF. The need to revisit ochratoxin A risk in light of diabetes, obesity, and chronic kidney disease prevalence. Food Chem Toxicol. 2017; 103:79-85. [DOI:10.1016/j.fct.2017.03.001]
13. Mitchell NJ, Chen C, Palumbo JD, Bianchini A, Cappozzo J,Stratton J. et al. A risk assessment of dietary Ochratoxin a in the United States. Food Chem Toxicol.2017; 100:265-73. [DOI:10.1016/j.fct.2016.12.037]
14. Gifford FJ, Gifford RM, Eddleston M, Dhaun N.Endemic nephropathy around the world. Kidney Int Rep. 2017; 2(2):282-92. [DOI:10.1016/j.ekir.2016.11.003]
15. Maor U, Sadhasivam S, Zakin V, Prusky D, Sionov E. The effect of ambient pH modulation on ochratoxin A accumulation by Aspergillus carbonarius. World Mycotoxin J. 2017; 10(4):339-48. [DOI:10.3920/WMJ2017.2200]
16. Pfohl-Leszkowicz A, Manderville RA. Ochratoxin A: an overview on toxicity and carcinogen icity in animals and humans. Mol Nutr Food Res. 2007; 51(1):61-99. [DOI:10.1002/mnfr.200600137]
17. Wood L, Jaspan H, Sodora D. Infant immune activation, HIV susceptibility and ochratoxin A exposure in Khayelitsha, South Africa (P6159).J Immunol.2013;190(1):118.
18. Tafuri A, Ferracane R, Ritieni A. Ochratoxin A in Italian marketed cocoa products. Food Chem. 2004; 88(4):487-94. [DOI:10.1016/j.foodchem.2004.01.061]
19. Petkova‚ÄźBocharova T, Castegnaro M. Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit Contam. 1985; 2(4):267-70. [DOI:10.1080/02652038509373555]
20. Dostal A, Jakusova L, Cajdova J, Hudeckova H. Results of the first studies of occurence of ochratoxin A in human milk in Slovakia. Bratisl Lek Listy. 2008;109(6):276-8.
21. Gurbay A, Sabuncuoglu SA, Girgin G, Sahin G, Yigit S, Yurdakok M, et al. Exposure of newborns to aflatoxin M1 and B1 from mothers' breast milk in Ankara, Turkey. Food Chem Toxicol. 2010; 48(1):314-9. [DOI:10.1016/j.fct.2009.10.016]
22. Navas SA, Sabino M, Rodriguez-Amaya DB. Aflatoxin M(1) and ochratoxin A in a human milk bank in the city of Sao Paulo, Brazil. Food Addit Contam. 2005;22(5):457-62. [DOI:10.1080/02652030500110550]
23. El-Sayed Abd Alla A,Neamat-Allah A, Aly SE. Situati on of mycotoxins in milk, dairy products and human milk in Egypt. Mycotoxin Res. 2000; 16(2):91-100. [DOI:10.1007/BF02946108]
24. Munoz K, Campos V, Blaszkewicz M, Vega M, Alvarez A, Neira J, et al. Exposure of neonates to ochratoxin A: first biomonitoring results in human milk (colostrum) from Chile. Mycotoxin Res. 2010;26(2):59-67. [DOI:10.1007/s12550-009-0040-0]
25. Creppy EE. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol Lett. 2002; 127(1-3):19-28. [DOI:10.1016/S0378-4274(01)00479-9]
26. Jonsyn FE, Maxwell SM, Hendrickse RG. Ochratoxin A and aflatoxins in breast milk sam ples from Sierra Leone. Mycopathologia. 1995; 131(2):121-6. [DOI:10.1007/BF01102890]
27. van Steenbergen WM, Kusin JA, de With C, Lacko E, Jansen AA. Lactation performance of mothers with contrasting nutritional status in rural Kenya. Acta Paediatr Scand. 1983; 72(6):805-10. [DOI:10.1111/j.1651-2227.1983.tb09820.x]
28. Skaug MA.Levels of ochratoxin A and IgG against conidia of Penicillium verrucosum in blood samples from healthy farm workers. Ann Agric Environ Med. 2003; 10(1):73-7. [DOI:10.1016/S0378-4274(03)90228-1]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2015 All Rights Reserved | Current Medical Mycology